Step 2/3
Percutaneous Ventricular Assist Device (pVADs)
Last updated on August 14, 2023
Related Content
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 31, 2023 
June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...
June 07, 2023 
March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...
March 01, 2023 
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...
November 02, 2022 
October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include ...
October 18, 2022 
August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling ...
August 25, 2022 
August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...
August 05, 2022 
June 23, 2022 — Medtronic, Inc. is recalling a single lot of HeartWare HVAD System batteries due to welding defects that ...
June 23, 2022 
June 8, 2022 — The U.S. Food and Drug Administration (FDA) has issued a release stating that Medtronic is recalling the ...
June 08, 2022 
April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...
April 28, 2022 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now